Literature DB >> 19474456

Molecular mechanism of recombinant liver fatty acid binding protein's antioxidant activity.

Jing Yan1, Yuewen Gong, Yi-Min She, Guqi Wang, Michael S Roberts, Frank J Burczynski.   

Abstract

Hepatocytes expressing liver fatty acid binding protein (L-FABP) are known to be more resistant to oxidative stress than those devoid of this protein. The mechanism for the observed antioxidant activity is not known. We examined the antioxidant mechanism of a recombinant rat L-FABP in the presence of a hydrophilic (AAPH) or lipophilic (AMVN) free radical generator. Recombinant L-FABP amino acid sequence and its amino acid oxidative products following oxidation were identified by MALDI quadrupole time-of-flight MS after being digested by endoproteinase Glu-C. L-FABP was observed to have better antioxidative activity when free radicals were generated by the hydrophilic generator than by the lipophilic generator. Oxidative modification of L-FABP included up to five methionine oxidative peptide products with a total of approximately 80 Da mass shift compared with native L-FABP. Protection against lipid peroxidation of L-FABP after binding with palmitate or alpha-bromo-palmitate by the AAPH or AMVN free radical generators indicated that ligand binding can partially block antioxidant activity. We conclude that the mechanism of L-FABP's antioxidant activity is through inactivation of the free radicals by L-FABP's methionine and cysteine amino acids. Moreover, exposure of the L-FABP binding site further promotes its antioxidant activity. In this manner, L-FABP serves as a hepatocellular antioxidant.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19474456      PMCID: PMC2781316          DOI: 10.1194/jlr.M900177-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  53 in total

Review 1.  Cellular fatty acid-binding proteins: their function and physiological significance.

Authors:  J F Glatz; G J van der Vusse
Journal:  Prog Lipid Res       Date:  1996-09       Impact factor: 16.195

2.  Fatty acid binding proteins reduce 15-lipoxygenase-induced oxygenation of linoleic acid and arachidonic acid.

Authors:  B A Ek; D P Cistola; J A Hamilton; T L Kaduce; A A Spector
Journal:  Biochim Biophys Acta       Date:  1997-05-17

3.  Expression of a recombinant form of the V antigen of Yersinia pestis, using three different expression systems.

Authors:  S Carr; J Miller; S E Leary; A M Bennett; A Ho; E D Williamson
Journal:  Vaccine       Date:  1999-08-20       Impact factor: 3.641

Review 4.  Serum lipoproteins structure and function.

Authors:  A M Scanu; C Wisdom
Journal:  Annu Rev Biochem       Date:  1972       Impact factor: 23.643

Review 5.  Acyl-CoA binding proteins: multiplicity and function.

Authors:  R E Gossett; A A Frolov; J B Roths; W D Behnke; A B Kier; F Schroeder
Journal:  Lipids       Date:  1996-09       Impact factor: 1.880

6.  Microsomal lipid peroxidation.

Authors:  J A Buege; S D Aust
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

7.  Interaction of vitamin E with saturated phospholipid bilayers.

Authors:  J B Massey; H S She; H J Pownall
Journal:  Biochem Biophys Res Commun       Date:  1982-06-15       Impact factor: 3.575

8.  Inhibition of binding to fatty acid binding protein reduces the intracellular transport of fatty acids.

Authors:  B A Luxon
Journal:  Am J Physiol       Date:  1996-07

9.  The crystal structure of the liver fatty acid-binding protein. A complex with two bound oleates.

Authors:  J Thompson; N Winter; D Terwey; J Bratt; L Banaszak
Journal:  J Biol Chem       Date:  1997-03-14       Impact factor: 5.157

Review 10.  Adduct formation, mutagenesis and nucleotide excision repair of DNA damage produced by reactive oxygen species and lipid peroxidation product.

Authors:  P Møller; H Wallin
Journal:  Mutat Res       Date:  1998-06       Impact factor: 2.433

View more
  23 in total

1.  Lipid droplet-associated kinase STK25 regulates peroxisomal activity and metabolic stress response in steatotic liver.

Authors:  Annika Nerstedt; Yeshwant Kurhe; Emmelie Cansby; Mara Caputo; Lei Gao; Egor Vorontsov; Marcus Ståhlman; Esther Nuñez-Durán; Jan Borén; Hanns-Ulrich Marschall; Douglas G Mashek; Darren N Saunders; Carina Sihlbom; Andrew J Hoy; Margit Mahlapuu
Journal:  J Lipid Res       Date:  2019-12-19       Impact factor: 5.922

2.  Fluorescent n-3 and n-6 very long chain polyunsaturated fatty acids: three-photon imaging in living cells expressing liver fatty acid-binding protein.

Authors:  Avery L McIntosh; Huan Huang; Barbara P Atshaves; Elizabeth Wellberg; Dmitry V Kuklev; William L Smith; Ann B Kier; Friedhelm Schroeder
Journal:  J Biol Chem       Date:  2010-04-09       Impact factor: 5.157

3.  Single-Cell Transcriptome Analysis of Mouse Liver Cell-Specific Tropism and Transcriptional Dysregulation Following Intravenous Administration of AAVrh.10 Vectors.

Authors:  Detu Zhu; Mahboubeh R Rostami; Wu-Lin Zuo; Philip L Leopold; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2020-04-24       Impact factor: 5.695

Review 4.  Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy.

Authors:  Blessy George; Melanie S Joy; Lauren M Aleksunes
Journal:  Exp Biol Med (Maywood)       Date:  2017-12-12

5.  Ablating L-FABP in SCP-2/SCP-x null mice impairs bile acid metabolism and biliary HDL-cholesterol secretion.

Authors:  Gregory G Martin; Barbara P Atshaves; Kerstin K Landrock; Danilo Landrock; Stephen M Storey; Philip N Howles; Ann B Kier; Friedhelm Schroeder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-02       Impact factor: 4.052

6.  Human FABP1 T94A variant enhances cholesterol uptake.

Authors:  Huan Huang; Avery L McIntosh; Kerstin K Landrock; Danilo Landrock; Stephen M Storey; Gregory G Martin; Shipra Gupta; Barbara P Atshaves; Ann B Kier; Friedhelm Schroeder
Journal:  Biochim Biophys Acta       Date:  2015-02-27

7.  Loss of L-FABP, SCP-2/SCP-x, or both induces hepatic lipid accumulation in female mice.

Authors:  Gregory G Martin; Barbara P Atshaves; Kerstin K Landrock; Danilo Landrock; Friedhelm Schroeder; Ann B Kier
Journal:  Arch Biochem Biophys       Date:  2015-06-24       Impact factor: 4.013

8.  Susceptibility of L-FABP-/- mice to oxidative stress in early-stage alcoholic liver.

Authors:  Rebecca L Smathers; James J Galligan; Colin T Shearn; Kristofer S Fritz; Kelly Mercer; Martin Ronis; David J Orlicky; Nicholas O Davidson; Dennis R Petersen
Journal:  J Lipid Res       Date:  2013-01-28       Impact factor: 5.922

9.  Salivary and serum biomarkers for the study of side effects of aripiprazole coprescribed with mirtazapine in rats.

Authors:  Maria Bogdan; Isabela Silosi; Petra Surlin; Andrei Adrian Tica; Oana Sorina Tica; Tudor-Adrian Balseanu; Anne-Marie Rauten; Adrian Camen
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 10.  Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias.

Authors:  Friedhelm Schroeder; Avery L McIntosh; Gregory G Martin; Huan Huang; Danilo Landrock; Sarah Chung; Kerstin K Landrock; Lawrence J Dangott; Shengrong Li; Martin Kaczocha; Eric J Murphy; Barbara P Atshaves; Ann B Kier
Journal:  Lipids       Date:  2016-04-27       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.